Platelet count: a simple measure of activity in Crohn's disease.
作者信息
Harries A D, Fitzsimons E, Fifield R, Dew M J, Rhoades J
出版信息
Br Med J (Clin Res Ed). 1983 May 7;286(6376):1476. doi: 10.1136/bmj.286.6376.1476.
Abstract
摘要
相似文献
1
Platelet count: a simple measure of activity in Crohn's disease.
Br Med J (Clin Res Ed). 1983 May 7;286(6376):1476. doi: 10.1136/bmj.286.6376.1476.
2
Platelet number and size in relation to serum orosomucoid concentration in Crohn's disease.
Med Lab Sci. 1989 Jan;46(1):79-80.
3
Platelet count in patients with Crohn's disease.
Br Med J (Clin Res Ed). 1983 Jun 11;286(6381):1895-6. doi: 10.1136/bmj.286.6381.1895-a.
4
[Use of the ratio of orosomucoid and prealbumin values as an indicator of the activity of Crohn's disease].
Cas Lek Cesk. 1982 Dec;121(48):1493-4.
5
Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in Crohn's disease: The controversy remains.
Clin Res Hepatol Gastroenterol. 2018 Feb;42(1):e16-e18. doi: 10.1016/j.clinre.2017.07.001. Epub 2017 Aug 7.
6
The acute phase protein response in Crohn's colitis.
Biochem Soc Trans. 1991 Apr;19(2):222S. doi: 10.1042/bst019222s.
7
Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.
Gut. 1990 Sep;31(9):1033-6. doi: 10.1136/gut.31.9.1033.
8
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.
N Engl J Med. 1995 Feb 2;332(5):292-7. doi: 10.1056/NEJM199502023320503.
9
Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.
Gut. 1981 Jul;22(7):571-4. doi: 10.1136/gut.22.7.571.
10
[Thrombocytes as an indicator of activity in Crohn's disease treated with total parenteral and/or enteral nutrition].
Vnitr Lek. 1994 Feb;40(2):84-8.
引用本文的文献
1
Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea.
Intest Res. 2024 Jul;22(3):336-350. doi: 10.5217/ir.2023.00077. Epub 2024 Mar 26.
2
Dysregulated haemostasis in thrombo-inflammatory disease.
Clin Sci (Lond). 2022 Dec 22;136(24):1809-1829. doi: 10.1042/CS20220208.
3
Therapeutic efficacy of rifaximin loaded tamarind gum polysaccharide nanoparticles in TNBS induced IBD model Wistar rats.
Rep Pract Oncol Radiother. 2021 Sep 30;26(5):712-729. doi: 10.5603/RPOR.a2021.0100. eCollection 2021.
4
The risk of venous thromboembolic events in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Ann Gastroenterol. 2021 Sep-Oct;34(5):680-690. doi: 10.20524/aog.2021.0631. Epub 2021 May 27.
5
Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study.
RMD Open. 2020 Sep;6(3). doi: 10.1136/rmdopen-2020-001392.
6
Platelet factor 4 is a biomarker for lymphatic-promoted disorders.
JCI Insight. 2020 Jul 9;5(13):135109. doi: 10.1172/jci.insight.135109.
7
Whole-Genome DNA Methylation Profiling of CD14+ Monocytes Reveals Disease Status and Activity Differences in Crohn's Disease Patients.
J Clin Med. 2020 Apr 8;9(4):1055. doi: 10.3390/jcm9041055.
8
Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease.
Clin Transl Gastroenterol. 2020 Mar;11(3):e00138. doi: 10.14309/ctg.0000000000000138.
9
ADAMTS13 Deficiency Worsens Colitis and Exogenous ADAMTS13 Administration Decreases Colitis Severity in Mice.
TH Open. 2017 Jun;1(1):e11-e23. doi: 10.1055/s-0037-1603927.
10
Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease: A pilot study.
Medicine (Baltimore). 2017 Mar;96(11):e6323. doi: 10.1097/MD.0000000000006323.
本文引用的文献
1
Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.
Gut. 1981 Jul;22(7):571-4. doi: 10.1136/gut.22.7.571.
2
A simple index of Crohn's-disease activity.
Lancet. 1980 Mar 8;1(8167):514. doi: 10.1016/s0140-6736(80)92767-1.
3
Thrombocytosis in chronic inflammatory bowel disease.
Ann Intern Med. 1968 May;68(5):1013-21. doi: 10.7326/0003-4819-68-5-1013.
4
Thrombocytosis in ulcerative colitis and Crohn's disease.
Scand J Gastroenterol. 1973;8(2):135-8.
5
Coagulation studies in ulcerative colitis and Crohn's disease.
Gastroenterology. 1975 Feb;68(2):245-51.
Zotero 插件